Related Experiment Videos
[Macroangiopathy in diabetes mellitus]
1Schweizerisches Herz- und Gefässzentrum, Inselspital Bern, Schweiz. manuela.birrer@pop.agri.ch
VASA. Zeitschrift Fur Gefasskrankheiten
|October 5, 2001
Summary
Hyperglycemia contributes to diabetic macro- and microangiopathy, increasing risks for cardiovascular and cerebrovascular diseases. Stringent blood glucose control may attenuate microvascular damage, though its effect on macroangiopathy remains unclear.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Vascular Biology
Context:
- Diabetic angiopathy lacks specific histological markers, often presenting as a severe form of atherosclerosis.
- Hyperglycemia is the primary driver of both macro- and microvascular complications in diabetes mellitus.
- Diabetic foot ulcers, though mainly neuropathic, are frequently linked with peripheral vascular disease (PVD).
Purpose:
- To review the relationship between hyperglycemia and arteriosclerosis in diabetic patients.
- To explore current treatment strategies for managing vascular complications in diabetes.
- To evaluate the impact of glycemic control on macro- and microvascular outcomes.
Summary:
- Hyperglycemia directly harms the arterial wall and causes endothelial dysfunction, contributing to premature arteriosclerosis.
- Diabetic patients face significantly higher risks of PVD, myocardial infarction, and stroke.
- While stringent glycemic control shows promise in reducing microvascular lesions, its effect on macrovascular disease prevention is not yet definitively established.
Impact:
- This review highlights the critical role of hyperglycemia in diabetic vascular disease.
- It underscores the importance of managing blood glucose levels for mitigating microvascular complications.
- Findings suggest that while macrovascular risk reduction may not be directly linked to tight glucose control, it remains a crucial aspect of comprehensive diabetes care.